Leerink Partnrs Issues Optimistic Outlook for WBA Earnings

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Stock analysts at Leerink Partnrs raised their Q1 2025 earnings estimates for Walgreens Boots Alliance in a report released on Tuesday, October 15th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will earn $0.40 per share for the quarter, up from their prior estimate of $0.37. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $2.85 per share. Leerink Partnrs also issued estimates for Walgreens Boots Alliance’s Q2 2025 earnings at $0.47 EPS, FY2025 earnings at $1.53 EPS, FY2026 earnings at $1.64 EPS, FY2027 earnings at $1.75 EPS and FY2028 earnings at $1.82 EPS.

Several other research analysts have also recently weighed in on the stock. Royal Bank of Canada lowered their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research report on Tuesday, July 2nd. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. UBS Group raised their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday, October 7th. Finally, TD Cowen cut their target price on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, September 12th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $13.38.

Walgreens Boots Alliance Trading Up 1.2 %

WBA opened at $10.79 on Friday. The firm has a market capitalization of $9.31 billion, a price-to-earnings ratio of -1.60, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. The company’s 50 day simple moving average is $9.41 and its two-hundred day simple moving average is $13.14. Walgreens Boots Alliance has a 1-year low of $8.22 and a 1-year high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same quarter last year, the firm posted $0.67 EPS. The firm’s revenue for the quarter was up 5.9% on a year-over-year basis.

Institutional Trading of Walgreens Boots Alliance

A number of institutional investors have recently bought and sold shares of WBA. New Covenant Trust Company N.A. acquired a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at $35,000. Iron Horse Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares in the last quarter. FinTrust Capital Advisors LLC grew its holdings in shares of Walgreens Boots Alliance by 60.4% during the first quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 802 shares during the last quarter. Blue Trust Inc. increased its position in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 1,081 shares in the last quarter. Finally, Continuum Advisory LLC lifted its holdings in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,020 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.